StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.55−0.09 (-5.49%)

Close on Nov 18, 2026Market cap $11.15MP/E 1.1Yield –

Chemomab Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Chemomab Therapeutics

Chemomab Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Chemomab Therapeutics figures

See a number that looks wrong?